Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2108550-78-1 | 4-Hydrazinyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester ethanedioate (1:1) | Csub10/subHsub21/subNsub3/subOsub2/sub.Csub2/subHsub2/subOsub4/sub |
| 2108968-20-1 | Venlafaxine EP Impurity G | Csub17/subHsub28/subClNO |
| 2115779-15-0 | Pantoprazole EP Impurity E | Csub32/subHsub28/subFsub4/subNsub6/subOsub8/subSsub2/sub |
| 2116542-19-7 | 7-[4-[(2-oxo-1H-quinolin-7-yl)oxy]butoxy]-1H-quinolin-2-one | Csub22/subHsub20/subNsub2/subOsub4/sub |
| 2117346-85-5 | Nicotinamide-13C3,15N | Csub3/subsupsub13/sub/supCsub3/subHsub6/subNsupsub15/sub/supNO |
| 2117703-26-9 | Dacomitinib Impurity SFAJ | Csub15/subHsub12/subFsub2/subNsub4/subO |
| 2118954-10-0 | (3-exo)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-amine hydrochloride (1:2) | Csub9/subHsub18/subNsub2/sub.2(HCl) |
| 2118959-55-8 | Ephos | Csub36/subHsub55/subOP |
| 2119574-93-3 | 5,6,7,8-Tetrahydro-4H-thiazolo[4,5-d]azepin-2-amine hydrochloride | Csub7/subHsub11/subNsub3/subS.HCl |
| 2119588-41-7 | (S)-2-aminopropanenitrile 4-methylbenzenesulfonate | Csub10/subHsub14/subNsub2/subOsub3/subS |
| 2119689-75-5 | Dacomitinib Impurity SFXJ | Csub15/subHsub10/subFsub2/subNsub4/subOsub3/sub |
| 2124272-05-3 | Rosuvastatin Impurity 35 | Csub13/subHsub24/subOsub5/sub |
| 2124275-54-1 | Rosuvastatin Impurity 30 | Csub13/subHsub22/subOsub5/sub |
| 2125472-55-9 | (2-Chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4-(((S)-tetrahydrofuran-3-yl)oxy)phenyl)methanone | Csub23/subHsub25/subClOsub8/sub |
| 2125473-29-0 | 2-Chloro-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine | Csub15/subHsub9/subClsub2/subNsub3/sub |
| 2126088-17-1 | N-[(2S)-2-Azetidinylmethyl]carbamic acid 1,1-dimethylethyl ester hydrochloride | Csub9/subHsub18/subNsub2/subOsub2/sub.HCl |
| 2126177-46-4 | [4-(Trifluoromethyl)piperidin-4-yl]methanol hydrochloride | Csub7/subHsub13/subClFsub3/subNO |
| 2127387-65-7 | Bempedoic acid impurity 16 | Csub19/subHsub34/subOsub4/sub |
| 2128291-05-2 | 4-Bromobenzo[1,2-b:3,4-b']bisbenzofuran | Csub18/subHsub9/subBrOsub2/sub |
| 2130840-90-1 | Levofloxacin-007-S | Csub20/subHsub25/subFNsub4/subOsub4/sub |
| 2130840-92-3 | Levofloxacin Impurity 8-S | Csub20/subHsub24/subFNsub3/subOsub4/sub |
| 2131025-93-7 | Eltrombopag Olamine impurity 02 | Csub32/subHsub28/subNsub4/subOsub4/sub |
| 2132949-19-8 | 2-[[4-Chloro-2-(trifluoromethyl)phenyl]methyl]-1H-indole-5-carboxylic acid methyl ester | Csub18/subHsub13/subClFsub3/subNOsub2/sub |
| 2132978-44-8 | EPhos Pd G4 | Csub50/subHsub70/subNOsub4/subPPdS |
| 2133360-04-8 | Pomalidomide-PEG1-azide | Csub17/subHsub16/subNsub6/subOsub6/sub |
| 2133460-43-0 | (3S,5R,6R)-Bupropion Impurity | Csub12/subHsub14/subClNOsub3/subS |
| 2134109-10-5 | Ibrutinib Impurity 17 | Csub16/subHsub18/subNsub6/subO |
| 2135576-73-5 | Vortioxetine Impurity 24 | Csub19/subHsub22/subNsub2/subOS |
| 2135600-87-0 | (5-Fluoro-2,3-dihydrobenzofuran-4-yl)methanamine hydrochloride | Csub9/subHsub11/subClFNO |
| 2136287-59-5 | Methyl 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylate | Csub19/subHsub22/subNsub2/subOsub6/sub |
| 2136287-61-9 | tert-Butyl (3-(benzyloxy)-2-((2-(2,2-dimethoxyethoxy)ethyl)carbamoyl)-4-oxopyridin-1(4H)-yl)carbamate | Csub24/subHsub33/subNsub3/subOsub8/sub |
| 2136287-65-3 | 3,4-Difluoro-2-((phenylthio)methyl)benzoic acid | Csub14/subHsub10/subFsub2/subOsub2/subS |
| 2136287-66-4 | 7,8-Difluoro-dibenzo[b,e]thiepin-11(6H)-one | Csub14/subHsub8/subFsub2/subOS |
| 2137047-43-7 | 3-(2,3-Difluoro-4-methoxyphenyl)-2,5-dimethyl-7-(trifluoromethyl)-pyrazolo[1,5-a]pyrimidine | Csub16/subHsub12/subFsub5/subNsub3/subO |
| 2137418-13-2 | (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(hydroxy(4-(((S)-tetrahydrofuran- 3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H- pyran-3,4,5-triol | Csub23/subHsub27/subClOsub8/sub |
| 2137722-14-4 | Vortioxetine impurity 04 | Csub18/subHsub23/subClNsub2/subS |
| 2137744-33-1 | N-[1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]formamide | Csub26/subHsub28/subNsub8/subOsub3/sub |
| 2137793-92-9 | Vortioxetine Impurity 11 | Csub18/subHsub23/subClNsub2/subS |
| 2137823-20-0 | Brexpiprazole Impurity 52 | Csub41/subHsub47/subNsub5/subOsub2/subSsub2/sub |
| 2137894-01-8 | 6-Bromo-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline | Csub10/subHsub9/subBrFsub3/subN |
| 2137919-55-0 | 2-(3-Chlorophenyl)-4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazine | Csub27/subHsub16/subClNsub3/subO |
| 2137975-08-5 | CPD1563 | Csub20/subHsub26/subNsub6/subOsub3/sub |
| 2138169-93-2 | Brexpiprazole Impurity 31 | Csub41/subHsub47/subNsub5/subOsub2/subSsub2/sub |
| 2138299-34-8 | diABZI STING agonist-1 trihydrochloride | Csub42/subHsub54/subClsub3/subNsub13/subOsub7/sub |
| 2138392-83-1 | Linagliptin Impurity B | Csub26/subHsub21/subBrNsub8/subOsub2/sub |
| 2138463-93-9 | (3R)-3-Hydroxybutanoic acid calcium salt (2:1) | Ca(Csub4/subHsub7/subOsub3/sub)sub2/sub |
| 2138475-71-3 | Rel-(1R,5S,6r)-3,3-difluorobicyclo[3.1.0]hexan-6-amine | Csub6/subHsub9/subFsub2/subN |
| 2138490-84-1 | 2-Bromo-6-chlorodibenzo[b,d]furan | Csub12/subHsub6/subBrClO |
| 2138498-18-5 | diABZI STING agonist-1 | Csub42/subHsub51/subNsub13/subOsub7/sub |
| 2138805-26-0 | Linagliptine Chloro Impurity | Csub25/subHsub29/subClNsub8/subOsub2/sub |